These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2515880)

  • 1. Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.
    Pedersen C; Ingeberg S; Teglbjaerg LS
    AIDS; 1989 Nov; 3(11):743-6. PubMed ID: 2515880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Richman DD; Fischl MA; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Hirsch MS
    N Engl J Med; 1987 Jul; 317(4):192-7. PubMed ID: 3299090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
    van der Wouw PA; van Leeuwen R; van Oers RH; Lange JM; Danner SA
    Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
    Casoli C; Magnani G; Schianchi C; Barchi E; Bertazzoni U
    AIDS; 1990 Aug; 4(8):799-802. PubMed ID: 2261134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thymidine kinase (TK) evaluation in HIV infection.
    Sabbatani S; Fini A; Raise E; Gritti FM
    Int J Biol Markers; 1989; 4(1):40-4. PubMed ID: 2746046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
    Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL; Mathiesen LR; Søeberg B; Nielsen L; Thorsen B; Buhl M; Pedersen C; Bonnevie O; Nielsen C; Vestergaard BF
    Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec; 26(26):101-4. PubMed ID: 3065024
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
    Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
    J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
    AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
    Fischl MA; Richman DD; Causey DM; Grieco MH; Bryson Y; Mildvan D; Laskin OL; Groopman JE; Volberding PA; Schooley RT
    JAMA; 1989 Nov; 262(17):2405-10. PubMed ID: 2677429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thymidine kinase in AIDS patients treated with zidovudine.
    Pedersen C; Ingeberg S
    Lancet; 1987 Aug; 2(8556):460. PubMed ID: 2887768
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group.
    Cooper DA; Pedersen C; Aiuti F; Vilde JL; Ruhnke M; Pehrson PO; Clumeck N; Farthing C; Lüthy R; Doherty RR
    AIDS; 1991 Aug; 5(8):933-43. PubMed ID: 1777174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.
    Connolly KJ; Allan JD; Fitch H; Jackson-Pope L; McLaren C; Canetta R; Groopman JE
    Am J Med; 1991 Nov; 91(5):471-8. PubMed ID: 1659189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study Group.
    Swanson CE; Cooper DA
    AIDS; 1990 Aug; 4(8):749-57. PubMed ID: 1979744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
    van Leeuwen R; van den Hurk PJ; Jöbsis GJ; van der Wouw PA; Reiss P; Eeftinck Schattenkerk JK; Danner SA; Lange JM
    Genitourin Med; 1990 Dec; 66(6):418-22. PubMed ID: 2125023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.